⌘K

Login Start Free

Home/Filings/4/0001209191-05-030617

4//SEC Filing

ANADYS PHARMACEUTICALS INC 4

Accession 0001209191-05-030617

CIK 0001128495operating

View on SEC.gov Company Profile

Filed

Jun 6, 8:00 PM ET

Accepted

Jun 7, 6:25 PM ET

Size

5.6 KB

Accession

0001209191-05-030617

Insider Transaction Report

Form 4

Period: 2005-06-03

ANADYS PHARMACEUTICALS INCANDS

FOTIADIS MARIOS

Director

Transactions

Award
Stock Option (Right to Buy)
2005-06-03+5,000→ 5,000 total
Exercise: $8.37From: 2005-07-03Exp: 2015-06-02→ Common Stock (5,000 underlying)

Footnotes (1)

[F1]1/36th of the shares subject to this option shall vest and become exercisable monthly over a three year period starting on 07/03/2005.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ANADYS PHARMACEUTICALS INC

CIK 0001128495

Entity typeoperating

Related Parties

1

filerCIK 0001128495

Filing Metadata

Form type: 4
Filed: Jun 6, 8:00 PM ET
Accepted: Jun 7, 6:25 PM ET
Size: 5.6 KB

View on SEC.gov